Abstract
Background & Aims: Gut-associated dendritic cells (DC) metabolize vitamin A into all-trans retinoic acid (RA), which is required to induce lymphocytes to localize to the gastrointestinal tract and promotes the differentiation of Foxp3+ regulatory T cells and IgA antibody-secreting cells. We investigated whether RA functions in a positive-feedback loop in DC to induce its own synthesis. Methods: We measured levels of retinoids in intestinal tissues from mice and assessed the role of RA in the functional specialization of gut-associated DC in cell cultures and mice. We used pharmacologic antagonists to determine the signaling pathways involved in regulation of DC and used MyD88-/- mice to determine the contribution of Toll-like receptor signaling in RA-mediated effects on DC. Results: The concentration of retinoids decreased in a proximal-to-distal gradient along the intestine, which correlated with the activity of gut-specific DC. Importantly, RA regulated the ability of gut-associated DC to produce RA, induce T cells to localize to the gastrointestinal tract, and generate regulatory T cells and IgA-secreting cells. RA was sufficient to induce its own production by extraintestinal DC in vitro and in vivo. RA-mediated regulation of DC required signaling through the mitogen-activated protein kinase signaling pathway and unexpectedly required MyD88, which is conventionally associated with Toll-like receptor, interleukin-1, and interleukin-18 signaling. Conclusions: RA is necessary and sufficient to induce DC to regulate T-cell localization to the gastrointestinal tract and IgA secretion. Our findings also indicate crosstalk between the RA receptor and MyD88-dependent Toll-like receptor signaling pathways.
Original language | English |
---|---|
Pages (from-to) | 176-185 |
Number of pages | 10 |
Journal | Gastroenterology |
Volume | 141 |
Issue number | 1 |
DOIs | |
State | Published - 2011 |
Externally published | Yes |
Bibliographical note
Funding Information:Funding EJV was supported by a grant from Crohn's & Colitis Foundation of America . MRB and MR were supported by Fondecyt Grants 1100557 and 1100448 and PFB16 from Conicyt . UHvA was supported by grants from National Institutes of Health . JRM was supported by grants from Crohn's & Colitis Foundation of America , Cancer Research Institute , Howard H. Goodman (Massachusetts General Hospital) , Massachusetts Life Science Center , and National Institutes of Health DP2 2009A054301 .
ASJC Scopus subject areas
- Hepatology
- Gastroenterology